Healthcare / Health Information ServicesHKSE
$0.98
+0.03 (+3.16%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 33% · confianza 20%
FCF escenarios
weak_data · normalized FCF $36.1M · quality 48.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
38/100
D
Piotroski
3/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$537M
P/E
32.7x
↑EV/EBITDA
6.9x
↓ROE
1.5%
↑Gross Margin
59.3%
↑Debt/Equity
0.01
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
-8.2%
FCF CAGR
—
FCF margin
0.7%
FCF / Net income
0.11x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $270.4M · net income $17.9M · FCF $2.0M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $270.4M | $270.4M | $260.6M | $349.2M | $348.9M |
| Net Income | $17.9M | $17.9M | $25.0M | $55.0M | $-99.9M |
| EBITDA | $25.4M | $25.4M | $32.8M | $69.1M | $-87.6M |
| EPS | 0.03 | 0.03 | 0.05 | 0.08 | -0.16 |
| Gross Margin | 59.3% | 59.3% | 62.2% | 62.0% | 59.1% |
| Operating Margin | 11.4% | 11.4% | 0.2% | 12.3% | 1.8% |
| Net Margin | 6.6% | 6.6% | 9.6% | 15.8% | -28.6% |
| Balance Sheet | |||||
| Debt/Equity | 0.01 | 0.01 | 0.00 | 0.00 | -0.07 |
| Current Ratio | 6.73 | 6.73 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $2.0M | $2.0M | $54.5M | $36.1M | $-16.2M |
| Returns | |||||
| ROE | 1.5% | 1.5% | 2.1% | 4.9% | 70.2% |
| Valuation | |||||
| P/E | 32.67 | 32.67 | 16.00 | 50.38 | — |
| EV/EBITDA | 6.90 | 6.90 | 2.06 | 27.69 | — |
| P/B | 0.45 | 0.45 | 0.37 | 1.87 | — |
| Growth & Yield | |||||
| Revenue Growth | 3.7% | 3.7% | -25.4% | 0.1% | — |
| EPS Growth | -40.0% | -40.0% | -37.5% | 148.6% | — |
| Dividend Yield | 2.3% | 2.3% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
42.6%
EPS terminal req.
$0.09
Spread vs growth
-82.6%
5Y implied EPS CAGR
28.5%
EPS terminal req.
$0.11
Spread vs growth
-68.5%
10Y implied EPS CAGR
18.9%
EPS terminal req.
$0.17
Spread vs growth
-58.9%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-13.9%
Start / end P/E
23.4x → 32.7x
EPS bridge
0.05 → 0.03
Residual
-15.8%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.